Cristina Fernandez-Valle

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Traumatic Brain Injury

Tyrosine Kinase

Cell Proliferation

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Nagel, Julianne Huegel, Alejandra M Petrilli, Rosa Rosario, Berta Victoria, Haley M Hardin, Cristina Fernandez-Valle
Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis. Oncogene 43 (13) (2024)
Anna Nagel, Julianne Huegel, Alejandra M Petrilli, Rosa Rosario, Berta Victoria, Haley M Hardin, Cristina Fernandez-Valle
Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis. Oncogene 43 (13) (2024)
Anna Nagel, Julianne Huegel, Alejandra M Petrilli, Rosa Rosario, Berta Victoria, Haley M Hardin, Cristina Fernandez-Valle
Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis. Oncogene 43 (13) (2024)
Anna Nagel, Julianne Huegel, Alejandra M Petrilli, Rosa Rosario, Berta Victoria, Haley M Hardin, Cristina Fernandez-Valle
Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis. Oncogene (2024)
Anna Nagel, Julianne Huegel, Alejandra M Petrilli, Rosa Rosario, Berta Victoria, Haley M Hardin, Cristina Fernandez-Valle
Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis. Oncogene (2024)
Haley M Hardin, Christine T Dinh, Julianne Huegel, Alejandra M Petrilli, Olena Bracho, Abdulrahman Mamoon Allaf, Matthias A Karajannis, Anthony J Griswold, Michael E Ivan, Jacques Morcos, Sakir Humayun Gultekin, Fred F Telischi, Xue Zhong Liu, Cristina Fernandez-Valle
Co-targeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma Cells. Molecular cancer therapeutics (2023)